Chromosome 8q amplification is a common event observed in cancer. In this study, we used high-resolution array comparative genomic hybridization to resolve two neighboring regions on 8q that are both amplified in oral cancer. One region (at 8q24) contains the MYC oncogene, which is frequently overexpressed in many cancers, while the other region (at 8q22) represents a novel amplicon. The alignment of array comparative genomic hybridization profiles of 20 microdissected oral squamous cell carcinomas (OSCCs) revealed a B5 Mbp region of frequent copy number alteration. This region harbors 16 known genes. Gene expression analysis comparing 15 microdissected OSCC with 16 normal epithelium samples revealed overexpression specific to LRP12 but not the neighboring genes, dihydropyrimidinase and FOG2, suggesting that LRP12 may function as an oncogene in oral tumors.
Introduction
Oral cancer affects over 500 000 people worldwide each year with the major cause being related to tobacco and alcohol exposure (Krajina et al., 1975; Lowry, 1975) . Oral cancer is believed to arise through the accumulation of numerous genetic alterations (Vokes et al., 1993) . These alterations may activate oncogenes or disrupt tumor suppressor genes that play a crucial role in the development of the disease. While there have been numerous genetic and gene expression profiling attempts to identify these key alterations such as amplifications and deletions, few genes have been associated with oral cancer development.
In a previous study, we demonstrated that multiple regions of chromosome 8q are altered in head and neck squamous cell carcinomas (SCCs) (Garnis et al., 2004) . In this report, we describe the use of high-resolution array comparative genomic hybridization (CGH) that provides near complete coverage of 8q21-24 to profile a panel of microdissected oral squamous cell carcinomas (OSCCs) in order to define one of the recurrent amplifications at 8q22.
Results and discussion
In all, 22 formalin-fixed, paraffin-embedded OSCCs were microdissected and analysed using a microarray consisting of 165 human bacterial artificial chromosome (BAC) clones spanning 52 Mbp across 8q21 to 8q24. The identity of these clones is available at http://www.bccrc.ca/cg/OralCancer.html. The array construction has been described previously (Garnis et al., 2004) . Array CGH analysis detected genetic alteration in 18 cases. No alteration in copy number was observed in four of the cases, while five cases showed an increase in copy number for the entire region (all 165 BACs). The remaining 13 cases showed two distinct regions of amplification at both 8q22 and 8q24. As stated above, the amplification at 8q24 contains the MYC oncogene. The alignment of the 8q22 alterations in the 13 cases delineated a minimal region of alteration (MRA) of approximately 5.3 Mbp (Figure 1a and b) with a centromeric boundary at BAC RP11-346H21 and a telomeric boundary at BAC RP11-680F23. Figure 1c shows an array CGH profile of case 574T.
The 8q22 region is gene rich, with 16 RefSeq genes in the 5.3 Mbp MRA (summarized in Table 1 ). Four cancer-related genes reside in this region, although, as indicated in Table 1 , none have been previously associated with oral cancer. In this study, we focused on one of these genes, LRP12, previously called ST7 but recently renamed by Battle et al. (2003) , which encodes a low-density lipoprotein receptor-like protein that is associated with several cancer-related pathways, and has been localized to BAC clone RP11-437B2 by sequence alignment. This gene should not be confused with the well-studied ST7 gene on 7q31 (Dong and Sidransky, 2002) .
We assayed for differential expression of LRP12 and its two neighboring genes, Dihydropyrimidinase (DPYS) (immediately centromeric to LRP12) and Friend of GATA2 (FOG2) (immediately telomeric to LRP12) (Figure 2a-d) . RNA was extracted from the epithelium of 15 microdissected frozen OSCCs and from 16 oral epithelial specimens from individuals without cancer. The normal samples were relatively uniform in the expression levels of LRP12 with minor fluctuations observed between samples (Figure 2a and b) . In contrast to the normal samples, five of the 15 tumor samples showed the overexpression of LRP12 to levels 42 s.d. of the average normal value (Figure 2b ). Table 1 . (c) BAC array CGH profile of sample 574T. Data are displayed as a normalized signal ratio between tumor and reference DNA for each BAC clone. Each data point represents the average of three replicate spots on the array and includes the standard deviation. Shading indicates large regions with copy number increase, which contains LRP12 at 8q22 and MYC at 8q24 LRP12 overexpression in oral squamous cell carcinoma C Garnis et al Our observations that LRP12 is overexpressed in oral tumors is inconsistent with the work by Qing et al. in the fibrosarcoma cell line model, which report a decrease in the expression of LRP12 associated with the transformation of a fibroblast cell line to a tumorigenic derivative. LRP12 is not expressed in fibrosarcoma cells or is greatly downregulated at the mRNA and protein levels when compared with the parental fibroblasts or other normal human fibroblasts. This difference could be associated with the usage of a transformed cell line (MSU-1.1) for determining the normal expression baseline of LRP12. Our observations indicate that LRP12 does not behave as a tumor suppressor gene and is likely a proto-oncogene in the context of oral cancer. However, the overexpression of LRP12 does not rule out the possibility of other overexpressed genes in this amplified region.
Archival material from formalin-fixed paraffin blocks was available for a subset of the cases used in the expression analysis above. This allowed us to test whether the overexpression of LRP12 is accompanied by genetic alteration. Although the amount of DNA recovered from the microdissected cancer cells was insufficient for array CGH analysis, we were able to examine these samples for loss of heterozygosity/allelic imbalance (LOH/AI) at D8S1459, a microsatelite marker mapping near LRP12 on BAC RP11-171O13 (Figure 1a) . Although microsatellite analysis does not distinguish between amplification and deletions, the data are consistent with a correlation between genetic alteration and LRP12 overexpression. Four tumors and three normal samples were polymorphic at D8S1459. Three of the four cases overexpressing LRP12 showed LOH/AI, while three cases with normal LRP12 expression exhibited retention of both alleles. Furthermore, we observed genetic alteration in oral premalignant lesions, with seven of 21 microdissected dysplastic lesions showing LOH/AI (data not shown).
In contrast to these results, the expression levels of the two genes flanking LRP12, DPYS and FOG2 (Figure 2c and d) were similar in both tumor and normal samples, suggesting that the overexpression is specific to LRP12 and not a consequence of regional upregulation. However, our study that focuses on LRP12 does not rule out the possibility of the presence of other differentially expressed genes in the 5.3 Mb region.
LRP12 belongs to the LDLR superfamily and may play a role in signal transduction (Qing et al., 1999) . Battle et al. (2003) showed that the cytoplasmic C terminus of LRP12 could interact with several proteins, including the receptor for activated protein C kinase 1 (RACK1), a protein that interacts with a myriad of cellular proteins, muscle integrin binding protein, which plays a role in myogenesis and SMAD anchor receptor activation, which interacts with the TGF-b pathway.
In summary, through the use of high-resolution array CGH, we have identified a recurrent 5.3 Mbp amplified region at 8q22 that is present in oral tumors. The LRP12 gene found in the 8q22 region showed an increase in gene expression in oral tumors, while the adjacent genes FOG2 and DPYS exhibited normal expression levels. The frequent amplification of the 8q22 genomic region in combination with the overexpression of LRP12 and the association of the LRP12 protein to pathways implicated in carcinogenesis suggests its involvement in head and neck epithelial carcinogenesis. Alteration at D8S1459 in oral dysplastic lesions suggests that the role of LRP12 in early oral cancer development should be further explored.
Materials and methods

Tissue samples
Archival dysplasia and tumor samples for array CGH and microsatellite analysis (formalin-fixed paraffin-embedded tissue blocks) were obtained from the British Columbia Oral Biopsy Service and the diagnoses were confirmed by an oral pathologist. Dysplastic, tumor and adjacent stromal cells were microdissected from hematoxylin-and eosin-stained sections LRP12 overexpression in oral squamous cell carcinoma C Garnis et al and DNA was isolated as described previously (Zhang et al., 1997) . Samples for gene expression analysis were collected within 15 min of surgery and frozen in liquid nitrogen. RNA was extracted from microdissected OSCCs and a panel of normal oral epithelium samples from individuals without cancer (Chomczynski and Sacchi, 1987) .
BAC array construction
Array CGH technology has been applied to several different tumor types in order to identify copy number gains and losses (Martinez-Climent et al., 2003; Paris et al., 2003; Veltman et al., 2003; Weiss et al., 2003) . In this study, a minimal overlapping tiling set of 165 RPCI-11 BAC clones representing 8q21-24 (B52 Mbp) was selected from the FPC database and the map location of sequenced clones was verified using the UCSC Human Genome Browser (Karolchik et al., 2003) . This clone list is publicly available at http://www.bccrc.ca/cg/OralCancer.html. The identity of each BAC DNA sample was confirmed based on its HindIII fingerprint. Mse1-digested BAC DNA was ligated to linkers (5 0 -AGTGGGATTCCGC ATGCTAGT-3 0 and 5 0 -TAACTAGCATGC-3 0 ) and amplified by PCR as described previously (Garnis et al., 2004 ). An aliquot of each PCR product was further amplified to produce sufficient DNA for spotting. The amplified DNA, dissolved in a 20% DMSO solution, was denatured by boiling for 10 min and rearrayed for robotic printing in triplicate using a VersArray ChipWriter Pro (BioRad, Mississauga, ON, Canada) with Stealth Micro Spotting Pins (Telechem/ArrayIT SMP2.5, Sunnyvale, CA, USA). Linker-mediated PCRamplified male human genomic DNA samples (Novagen, Madison, WI, USA) were spotted on the array in order to allow normalization of the hybridization signal intensities between dyes. The DNA was then covalently bonded to the slides by baking and UV crosslinking. Slides were then washed to remove unbound DNA.
Array CGH
Test and reference DNA of 100 ng were separately labeled using Cyanine 3 and Cyanine 5 dCTPs according to a previously described protocol (Garnis et al., 2004) . The DNA probes were denatured and annealed with 100 mg human Cot. 1 DNA 25 ml of DIG Easy hybridization solution (Roche, Laval, Quebec, Canada) containing 50 mg of sheared herring sperm DNA (Sigma-Aldrich, Oakville, ON, Canada) and 250 mg of yeast tRNA (Calbiochem, La Jolla, CA, USA). The BAC array slides were prehybridized at 421C for 1 h with DIG Easy hybridization buffer (Roche, Laval, Quebec, Canada) containing 1% BSA and 2 mg/ml sheared herring sperm DNA. The probe mixture was applied to the slide surface, coverslipped and incubated at 421C for 36 h. Arrays were washed five times for 5 min in 0.1 Â SSC, 0.1% SDS at room temperature with agitation. Each array was then rinsed five times in a clean slide box containing 0.1 Â SSC with agitation and dried by centrifugation.
Hybridized slides were imaged using a CCD-based imaging system (ArrayWorX e Auto, API, Issaquah, WA, USA) and analysed with SoftWoRx Tracker array analysis software. Spot signal data for each channel were normalized by applying a scale factor, which balanced the signal intensities of the human genomic DNA control spots. The average signal ratios and standard deviations for each triplicate spot set were calculated and displayed as a plot of the normalized Cyanine5/ Cyanine3 log 2 signal ratio versus relative tiling path position. A log 2 signal ratio of 0 at a spot represents equivalent copy number between the sample and reference DNA. Arrays were initially subjected to normal versus normal hybridizations for quality control (Veltman et al., 2003) . Spots that exhibited signal ratios outside of 3 s.d. from 0 in these experiments were discarded. This resulted in the establishment of a 70.2 log 2 ratio threshold for defining regions of copy number increase and decrease. Semiquantitative analysis of LRP12, DPYS and FOG2 expression cDNA was synthesized using the Superscript II RNAse H reverse transcriptase system (Invitrogen, Burlington, ON, Canada). GAPDH levels were used to normalize samples. Gene-specific primers were used to assay the quantity of LRP12 (5 0 -ACTGTAGTTCACTGT-3 0 , 5 0 -AGTTCAAGATG TGCT-3 0 ), DPYS (5 0 -CACAGCCTTTCCATC-3 0 , 5 0 -ACATT GTCAACCCAT-3 0 ), FOG2 (5 0 -CTGATGCAGCTCTGTCT AA-3 0 , 5 0 -TACTTGCAGCATTGAGTTTA-3 0 ) and GAPDH (5 0 -ACCTACCAAATATGATGACATCA-3 0 , 5 0 -CGCTGTT GAAGTCAGAGGA-3 0 ). PCR cycle conditions were as follows: one cycle of 951C, 1 min; 30 cycles of (951C, 30 s; 551C, 30 s; 721C, 1 min) and a 10 min extension at 721C. PCR products were resolved by polyacrylamide gel electrophoresis, imaged by SYBR green staining (Roche, Laval, Quebec, Canada) on a Storm phosphoimager, and quantified using ImageQuant software (Molecular Dynamics, Piscataway, NJ, USA).
Microsatellite analysis
Microsatellite analysis was performed to detect LOH/AI in specific chromosomal regions according to published protocols (Zhang et al., 1997) . For comparison, the underlying stroma was used as a source of matched control DNA. Signal ratios for microsatellite analysis were assessed using previously described criteria (Ng et al., 2000; Rosin et al., 2000) .
